WBI Investments’s Eli Lilly LLY Stock Holding History

WBI Investments’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-1,080	Closed	-$1.16M	–	355
2025 Q4	$1.16M	Buy	+1,080	New	+$1.03M	0.3%	86
2025 Q2	–	Sell	-400	Closed	-$330K	–	305
2025 Q1	$330K	Buy	+400	New	+$333K	0.09%	168
2021 Q3	–	Sell	-3,342	Closed	-$767K	–	210
2021 Q2	$767K	Buy	+3,342	New	+$671K	0.12%	108
2018 Q1	–	Sell	-233,094	Closed	-$19.7M	–	266
2017 Q4	$19.7M	Buy	+233,094	New	+$19.8M	0.91%	28
2017 Q3	–	Sell	-216,915	Closed	-$17.9M	–	338
2017 Q2	$17.9M	Buy	+216,915	New	+$17.7M	0.78%	28
2016 Q1	–	Sell	-857,977	Closed	-$72.3M	–	185
2015 Q4	$72.3M	Buy	857,977 +852,815	+16,521%	+$70.8M	2.07%	16
2015 Q3	$432K	Buy	+5,162	New	+$436K	0.01%	135
2014 Q1	–	Sell	-1,241,550	Closed	-$63.3M	–	126
2013 Q4	$63.3M	Buy	1,241,550 +700,095	+129%	+$35.1M	2.79%	7
2013 Q3	$27.3M	Buy	+541,455	New	+$28.3M	1.3%	26

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

WBI Investments's LLY Position: Q1 2026 in Review

WBI Investments sold out of Eli Lilly (LLY) in Q1 2026, closing a stake of 1,080 shares — an estimated $1.16M sold.

WBI Investments first reported a position in LLY in Q3 2013 and held it in 9 quarters. The position peaked at $72.3M in Q4 2015. 4,354 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

WBI Investments reported no remaining Eli Lilly position as of Q1 2026 after selling out during the quarter.
WBI Investments sold 1,080 Eli Lilly shares in Q1 2026, an estimated $1.16M.
WBI Investments first reported a position in Eli Lilly in Q3 2013 and held it in 9 quarters.
WBI Investments's Eli Lilly position peaked at $72.3M in Q4 2015.
4,354 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on WBI Investments's 13F filing for Q1 2026, filed 11 May 2026.